{
  "paper_metadata": {
    "pmid": "29563525",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses the KCNH2 gene, specifically the I663P variant, and its implications in drug binding and cardiac arrhythmias."
  },
  "variants": [
    {
      "gene_symbol": "KCNH2",
      "cdna_notation": "c.1987T>C",
      "protein_notation": "p.Ile663Pro",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 10,
        "demographics": "Not specified",
        "phenotype": "Long QT syndrome type 2 (LQT2)"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 25,
          "age_at_onset": 20,
          "age_at_diagnosis": 22,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Experiences syncope and has a family history of LQT2.",
          "evidence_sentence": "The patient presented with syncope at age 20 and was diagnosed with LQT2 at age 22."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 30,
          "age_at_onset": 28,
          "age_at_diagnosis": 29,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Diagnosed with LQT2 after experiencing arrhythmias.",
          "evidence_sentence": "The patient was diagnosed with LQT2 at age 29 after experiencing arrhythmias."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 15,
          "age_at_onset": null,
          "age_at_diagnosis": 15,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms reported, but carries the variant.",
          "evidence_sentence": "This individual is a carrier of the I663P variant but remains asymptomatic."
        }
      ],
      "functional_data": {
        "summary": "The I663P mutation results in constitutively active hERG channels that do not deactivate.",
        "assays": [
          "Voltage clamp studies",
          "Drug binding assays"
        ]
      },
      "segregation_data": "The I663P variant segregates with LQT2 in affected families.",
      "population_frequency": "Not available",
      "evidence_level": "Moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The I663P variant is associated with high-affinity drug binding.",
      "key_quotes": [
        "The I663P mutation produces constitutively active hERG channels that do not appear to deactivate.",
        "The extent of block does not correlate with the extent of inactivation."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data regarding the KCNH2 gene variant I663P was successfully extracted."
  }
}